financetom
Business
financetom
/
Business
/
Meta's chief revenue officer Hegeman leaves to launch startup
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta's chief revenue officer Hegeman leaves to launch startup
Nov 18, 2025 5:39 PM

(Reuters) -Meta's chief revenue officer John Hegeman said on Tuesday he will leave the Facebook parent to launch his own startup, marking a key leadership change amid the social media company's pursuit of superintelligence.

His key responsibilities will be taken over by another Meta executive, Andrew Bocking, who currently leads Meta's ads product and strategy team, according to Hegeman's Facebook post.

This comes after a Financial Times report last week that Meta's chief AI scientist Yann LeCun is planning to leave the company to set up his own startup.

The company has been stepping up its investments in building AI infrastructure, with CEO Mark Zuckerberg reorganizing the company's AI initiatives under Superintelligence Labs.

Earlier this year, Zuckerberg hired Alexandr Wang, former CEO of data-labeling startup Scale AI, to lead the new AI effort.

Hegeman, citing "mix of emotions" regarding his departure, credited Zuckerberg for the trust and support.

Head of product at Meta, Naomi Gleit, will become the head of business AI, Hegeman said in his post.

Clara Shih, who joined Meta last year to lead the business AI unit, is also leaving the company, according to Bloomberg News.

Shih chose to step down from her position following her father's unexpected death this year, according to the report.

Bloomberg News first reported Hegeman's departure.

Meta did not immediately respond to a Reuters request for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Insmed Prices $650 Million Public Offering
Insmed Prices $650 Million Public Offering
May 30, 2024
09:58 AM EDT, 05/30/2024 (MT Newswires) -- Insmed ( INSM ) said Thursday that it has priced its underwritten public offering of 12.6 million shares at $51.50 apiece for gross proceeds of $650 million. The biopharmaceutical company said it has granted the underwriters a 30-day option to buy up to an additional 1.9 million shares. Insmed ( INSM ) said...
Market Chatter: UBS Hit With Swiss Fine for Suspected Money Laundering by Former Yemeni President
Market Chatter: UBS Hit With Swiss Fine for Suspected Money Laundering by Former Yemeni President
May 30, 2024
09:59 AM EDT, 05/30/2024 (MT Newswires) -- UBS (UBS) has been hit with a 50,000 Swiss franc ($55,220) fine by the Swiss finance ministry for allegedly failing to report cases of suspected money laundering linked to the former president of Yemen Ali Abdullah Saleh, Bloomberg reported Wednesday. The probe had been launched in 2021 and it took two years for...
Hundreds of thousands of US internet routers destroyed in newly discovered 2023 hack
Hundreds of thousands of US internet routers destroyed in newly discovered 2023 hack
May 30, 2024
WASHINGTON, May 30 (Reuters) - - An unidentified hacking group launched a massive cyberattack on a telecommunications company in the U.S. heartland late last year that disabled hundreds of thousands of internet routers, according to research published Thursday. Security analysts with Lumen Technologies' ( LUMN ) Black Lotus Labs discovered the attack in recent months and reported on it in...
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs
May 30, 2024
May 30 (Reuters) - Novo Nordisk said on Thursday it had sued nine more medical spas, wellness clinics and pharmacies in the U.S. for selling products claiming to contain semaglutide, the key ingredient in its popular weight-loss drug Wegovy. The Danish drugmaker first filed lawsuits over the sale of copycat versions of semaglutide last June, later amending one after samples...
Copyright 2023-2026 - www.financetom.com All Rights Reserved